The Clinical and Economic Burden of Poorly Managed Schizophrenia

In this episode, "The Clinical and Economic Burden of Poorly Managed Schizophrenia," the panelists explore the cascading clinical and financial consequences of schizophrenia that is not diagnosed or managed effectively. Dr. Christoph Correll outlines how poorly controlled schizophrenia leads to residual positive, negative, and cognitive symptoms, increased risk of relapse and hospitalization, diminished quality of life, stigma, homelessness, suicidality, physical health complications, and ultimately premature mortality — all of which erode the path to recovery.

Dr. Correll draws attention to a landmark January 2026 paper by Krasa et al. in JAMA Psychiatry examining the national and state-level societal economic burden of schizophrenia in the United States. Representing approximately 3 million adults, the analysis estimates the total cost at $367 billion, with a per-person cost of nearly $120,000. Strikingly, only 20% of costs are direct — with healthcare comprising just 9% of the overall burden — while 80% are indirect, driven largely by caregiver-related expenses, lost productivity, and premature mortality.

Dr. Alva then prompts a cost comparison between relapse-driven inpatient stays and long-acting injectable antipsychotics. Dr. Correll notes that a single injection is roughly equivalent in cost to one to three days of hospitalization, meaning that avoided hospitalizations alone can offset the expense of injectables — while the indirect savings from improved patient stability, caregiver relief, and potential return to work or school represent an even greater opportunity. The segment closes with a strong emphasis on relapse prevention as the cornerstone of recovery and long-term cost reduction.

The next episode in this series, "Understanding the Multifactorial Causes of Non-Adherence in Schizophrenia," features the panelists examining the complex, interconnected patient, caregiver, and clinician factors that contribute to treatment non-adherence, and underscoring the importance of holistic, collaborative care in improving long-term outcomes.